Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban versus intravenous aspirin for tandem-lesion acute ischemic stroke undergoing endovascular treatment
2021-003874-30Phase 4Active
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in ischemic stroke comparing Tirofiban arm with Intravenous aspirin arm (2 arms). Primary endpoints: Carotid reocclusion and Symptomatic bleeding. Started Dec 2021; status: active.
02
Drugs
tirofibanlysine acetylsalicylate
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2021-003874-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003874-30.